Publication:
Effect of sitagliptin monotherapy on serum total ghrelin levels in people with type 2 diabetes.

Simple item page
dc.contributor.authorÖz, Ö
dc.contributor.authorKıyıcı, S
dc.contributor.authorErsoy, C
dc.contributor.authorCander, S
dc.contributor.authorYorulmaz, HAKAN
dc.contributor.authorGül, CB
dc.contributor.authorÜnal, OK
dc.contributor.authorSarandol, E
dc.contributor.authorKırhan, E
dc.contributor.authorSığırlı, D
dc.contributor.authorErtürk, E
dc.contributor.authorTuncel, E
dc.contributor.authorImamoğlu, S
dc.contributor.institutionauthorYORULMAZ, HAKAN
dc.date.accessioned2020-10-29T14:45:50Z
dc.date.available2020-10-29T14:45:50Z
dc.date.issued2011-11-01T00:00:00Z
dc.identifier.citationÖz Ö., Kıyıcı S., Ersoy C., Cander S., Yorulmaz H., Gül C., Ünal O., Sarandol E., Kırhan E., Sığırlı D., et al., -Effect of sitagliptin monotherapy on serum total ghrelin levels in people with type 2 diabetes.-, Diabetes research and clinical practice, cilt.94, ss.212-6, 2011
dc.identifier.doi10.1016/j.diabres.2011.07.031
dc.identifier.scopus81255160708
dc.identifier.urihttp://hdl.handle.net/20.500.12645/25436
dc.identifier.wosWOS:000297153500018
dc.titleEffect of sitagliptin monotherapy on serum total ghrelin levels in people with type 2 diabetes.
dc.typeArticle
dspace.entity.typePublication
local.avesis.id2c2c782c-a9a1-4a56-b006-1fa346918017
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublication8f56ea47-d85a-4cf2-9751-19621fc3fff7
relation.isAuthorOfPublication.latestForDiscovery8f56ea47-d85a-4cf2-9751-19621fc3fff7
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c
Files
Collections
Silinecekler